A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone
暂无分享,去创建一个
Reid F. Thompson | C. Drake | R. Bergan | G. Thomas | T. Beer | J. Alumkal | Yiyi Chen | Y. Koguchi | William L. Redmond | Mary A. Wood | E. Latour | Amy E. Moran | J. Graff | Rachel Slottke